Nivolumab in combination with ipilimumab versus capecitabine as post-operative treatment for triple negative breast cancer patients with residual disease after neoadjuvant chemotherapy: a multicentre, randomized, open-label phase II trial - BREASTIMMUNE-03
纳武利尤单抗联合伊匹木单抗对比卡培他滨作为新辅助化疗后残留病灶的三阴性乳腺癌患者术后治疗:一项多中心、随机、开放标签的II期试验 - BREASTIMMUNE-03
期刊:Breast
影响因子:7.9
doi:10.1016/j.breast.2025.104648
Trédan, Olivier; Loirat, Delphine; Chabaud, Sylvie; Toussaint, Philippe; Petit, Thierry; Viret, Frédéric; Levy, Christelle; Robert, Aurélien; Grenier, Julien; Mansi, Laura; Spano, Jean-Philippe; Patsouris, Anne; Derbel, Olfa; Jouannaud, Christelle; Ferrero, Jean Marc; Frenel, Jean Sébastien; Molin, Yann; Doublet, Louis; Heudel, Pierre-Etienne; Pierga, Jean-Yves; Garin, Gwenaële; Pérol, David; Bachelot, Thomas